{"id":23284,"date":"2020-07-07T00:00:00","date_gmt":"2020-07-07T05:00:00","guid":{"rendered":"https:\/\/myeloma.ca\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/"},"modified":"2020-07-07T00:00:00","modified_gmt":"2020-07-07T05:00:00","slug":"lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/","title":{"rendered":"Lancement de l\u2019essai mondial Selinexor pour traiter la COVID-19"},"content":{"rendered":"<p>Selinexor, un m&eacute;dicament approuv&eacute; par la Food and Drug Administration (FDA) pour le traitement des patients atteints d&rsquo;un my&eacute;lome multiple r&eacute;cidivant ou r&eacute;fractaire, est en cours d&rsquo;&eacute;valuation dans le cadre d&rsquo;un essai al&eacute;atoire mondial comme traitement potentiel pour les patients hospitalis&eacute;s atteints d&rsquo;une infection s&eacute;v&egrave;re &agrave; la COVID-19. Cliquez <a href=\"https:\/\/www.onclive.com\/view\/selinexor-covid19-global-trial-launching\" target=\"_blank\" rel=\"noopener\"><strong>ici <\/strong><\/a>pour en savoir plus (en anglais).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Selinexor, un m&eacute;dicament approuv&eacute; par la Food and Drug Administration (FDA) pour le traitement des patients atteints d&rsquo;un my&eacute;lome multiple r&eacute;cidivant ou r&eacute;fractaire, est en cours d&rsquo;&eacute;valuation dans le cadre d&rsquo;un essai al&eacute;atoire mondial comme traitement potentiel pour les patients hospitalis&eacute;s atteints d&rsquo;une infection s&eacute;v&egrave;re &agrave; la COVID-19. Cliquez ici pour en savoir plus (en [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[72],"tags":[],"class_list":["post-23284","post","type-post","status-publish","format-standard","hentry","category-actualites-et-nouvelles-au-sujet-de-la-covid-19"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Selinexor, un m\u00e9dicament approuv\u00e9 par la Food and Drug Administration (FDA) pour le traitement des patients atteints d\u2019un my\u00e9lome multiple r\u00e9cidivant ou r\u00e9fractaire, est en cours d\u2019\u00e9valuation dans le cadre d\u2019un essai al\u00e9atoire mondial comme traitement potentiel pour les patients hospitalis\u00e9s atteints d\u2019une infection s\u00e9v\u00e8re \u00e0 la COVID-19. Cliquez ici pour en savoir plus (en\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"lemieuxbedard\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/myeloma.ca\/fr\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_FR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"My\u00e9lome Canada |\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Lancement de l\u2019essai mondial Selinexor pour traiter la COVID-19 | My\u00e9lome Canada\" \/>\n\t\t<meta property=\"og:description\" content=\"Selinexor, un m\u00e9dicament approuv\u00e9 par la Food and Drug Administration (FDA) pour le traitement des patients atteints d\u2019un my\u00e9lome multiple r\u00e9cidivant ou r\u00e9fractaire, est en cours d\u2019\u00e9valuation dans le cadre d\u2019un essai al\u00e9atoire mondial comme traitement potentiel pour les patients hospitalis\u00e9s atteints d\u2019une infection s\u00e9v\u00e8re \u00e0 la COVID-19. Cliquez ici pour en savoir plus (en\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/myeloma.ca\/fr\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2020-07-07T05:00:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2020-07-07T05:00:00+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Lancement de l\u2019essai mondial Selinexor pour traiter la COVID-19 | My\u00e9lome Canada\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Selinexor, un m\u00e9dicament approuv\u00e9 par la Food and Drug Administration (FDA) pour le traitement des patients atteints d\u2019un my\u00e9lome multiple r\u00e9cidivant ou r\u00e9fractaire, est en cours d\u2019\u00e9valuation dans le cadre d\u2019un essai al\u00e9atoire mondial comme traitement potentiel pour les patients hospitalis\u00e9s atteints d\u2019une infection s\u00e9v\u00e8re \u00e0 la COVID-19. Cliquez ici pour en savoir plus (en\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2020\\\/07\\\/07\\\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\\\/#blogposting\",\"name\":\"Lancement de l\\u2019essai mondial Selinexor pour traiter la COVID-19 | My\\u00e9lome Canada\",\"headline\":\"Lancement de l\\u2019essai mondial Selinexor pour traiter la COVID-19\",\"author\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/stage.myeloma.ca\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo_en.png\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#articleImage\"},\"datePublished\":\"2020-07-07T00:00:00-05:00\",\"dateModified\":\"2020-07-07T00:00:00-05:00\",\"inLanguage\":\"fr-FR\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2020\\\/07\\\/07\\\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2020\\\/07\\\/07\\\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\\\/#webpage\"},\"articleSection\":\"Actualit\\u00e9s et nouvelles au sujet de la COVID-19, Optional\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2020\\\/07\\\/07\\\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/#listItem\",\"name\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/#listItem\",\"position\":2,\"name\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/actualites-et-nouvelles-au-sujet-de-la-covid-19\\\/#listItem\",\"name\":\"Actualit\\u00e9s et nouvelles au sujet de la COVID-19\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"name\":\"Accueil\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/actualites-et-nouvelles-au-sujet-de-la-covid-19\\\/#listItem\",\"position\":3,\"name\":\"Actualit\\u00e9s et nouvelles au sujet de la COVID-19\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/actualites-et-nouvelles-au-sujet-de-la-covid-19\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2020\\\/07\\\/07\\\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\\\/#listItem\",\"name\":\"Lancement de l\\u2019essai mondial Selinexor pour traiter la COVID-19\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/#listItem\",\"name\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2020\\\/07\\\/07\\\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\\\/#listItem\",\"position\":4,\"name\":\"Lancement de l\\u2019essai mondial Selinexor pour traiter la COVID-19\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/actualites-et-nouvelles-au-sujet-de-la-covid-19\\\/#listItem\",\"name\":\"Actualit\\u00e9s et nouvelles au sujet de la COVID-19\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\",\"name\":\"Myeloma Canada\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"telephone\":\"+18887985771\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/stage.myeloma.ca\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo_en.png\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2020\\\/07\\\/07\\\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2020\\\/07\\\/07\\\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/\",\"name\":\"lemieuxbedard\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2020\\\/07\\\/07\\\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/46bccf9afb319784ce7a4c49e51be67f2ed9bed19ab02f5f0a63c7aba8c80f06?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"lemieuxbedard\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2020\\\/07\\\/07\\\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\\\/#webpage\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2020\\\/07\\\/07\\\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\\\/\",\"name\":\"Lancement de l\\u2019essai mondial Selinexor pour traiter la COVID-19 | My\\u00e9lome Canada\",\"description\":\"Selinexor, un m\\u00e9dicament approuv\\u00e9 par la Food and Drug Administration (FDA) pour le traitement des patients atteints d\\u2019un my\\u00e9lome multiple r\\u00e9cidivant ou r\\u00e9fractaire, est en cours d\\u2019\\u00e9valuation dans le cadre d\\u2019un essai al\\u00e9atoire mondial comme traitement potentiel pour les patients hospitalis\\u00e9s atteints d\\u2019une infection s\\u00e9v\\u00e8re \\u00e0 la COVID-19. Cliquez ici pour en savoir plus (en\",\"inLanguage\":\"fr-FR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2020\\\/07\\\/07\\\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"datePublished\":\"2020-07-07T00:00:00-05:00\",\"dateModified\":\"2020-07-07T00:00:00-05:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"name\":\"Myeloma Canada\",\"inLanguage\":\"fr-FR\",\"publisher\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Lancement de l\u2019essai mondial Selinexor pour traiter la COVID-19 | My\u00e9lome Canada","description":"Selinexor, un m\u00e9dicament approuv\u00e9 par la Food and Drug Administration (FDA) pour le traitement des patients atteints d\u2019un my\u00e9lome multiple r\u00e9cidivant ou r\u00e9fractaire, est en cours d\u2019\u00e9valuation dans le cadre d\u2019un essai al\u00e9atoire mondial comme traitement potentiel pour les patients hospitalis\u00e9s atteints d\u2019une infection s\u00e9v\u00e8re \u00e0 la COVID-19. Cliquez ici pour en savoir plus (en","canonical_url":"https:\/\/myeloma.ca\/fr\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/myeloma.ca\/fr\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/#blogposting","name":"Lancement de l\u2019essai mondial Selinexor pour traiter la COVID-19 | My\u00e9lome Canada","headline":"Lancement de l\u2019essai mondial Selinexor pour traiter la COVID-19","author":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"publisher":{"@id":"https:\/\/myeloma.ca\/fr\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/stage.myeloma.ca\/wp-content\/uploads\/2023\/02\/logo_en.png","@id":"https:\/\/myeloma.ca\/fr\/#articleImage"},"datePublished":"2020-07-07T00:00:00-05:00","dateModified":"2020-07-07T00:00:00-05:00","inLanguage":"fr-FR","mainEntityOfPage":{"@id":"https:\/\/myeloma.ca\/fr\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/#webpage"},"isPartOf":{"@id":"https:\/\/myeloma.ca\/fr\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/#webpage"},"articleSection":"Actualit\u00e9s et nouvelles au sujet de la COVID-19, Optional"},{"@type":"BreadcrumbList","@id":"https:\/\/myeloma.ca\/fr\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","position":1,"name":"Accueil","item":"https:\/\/myeloma.ca\/fr\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/#listItem","name":"Actualit\u00e9s et \u00e9v\u00e9nement"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/#listItem","position":2,"name":"Actualit\u00e9s et \u00e9v\u00e9nement","item":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/actualites-et-nouvelles-au-sujet-de-la-covid-19\/#listItem","name":"Actualit\u00e9s et nouvelles au sujet de la COVID-19"},"previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","name":"Accueil"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/actualites-et-nouvelles-au-sujet-de-la-covid-19\/#listItem","position":3,"name":"Actualit\u00e9s et nouvelles au sujet de la COVID-19","item":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/actualites-et-nouvelles-au-sujet-de-la-covid-19\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/#listItem","name":"Lancement de l\u2019essai mondial Selinexor pour traiter la COVID-19"},"previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/#listItem","name":"Actualit\u00e9s et \u00e9v\u00e9nement"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/#listItem","position":4,"name":"Lancement de l\u2019essai mondial Selinexor pour traiter la COVID-19","previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/actualites-et-nouvelles-au-sujet-de-la-covid-19\/#listItem","name":"Actualit\u00e9s et nouvelles au sujet de la COVID-19"}}]},{"@type":"Organization","@id":"https:\/\/myeloma.ca\/fr\/#organization","name":"Myeloma Canada","url":"https:\/\/myeloma.ca\/fr\/","telephone":"+18887985771","logo":{"@type":"ImageObject","url":"https:\/\/stage.myeloma.ca\/wp-content\/uploads\/2023\/02\/logo_en.png","@id":"https:\/\/myeloma.ca\/fr\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/#organizationLogo"},"image":{"@id":"https:\/\/myeloma.ca\/fr\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author","url":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/","name":"lemieuxbedard","image":{"@type":"ImageObject","@id":"https:\/\/myeloma.ca\/fr\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/46bccf9afb319784ce7a4c49e51be67f2ed9bed19ab02f5f0a63c7aba8c80f06?s=96&d=mm&r=g","width":96,"height":96,"caption":"lemieuxbedard"}},{"@type":"WebPage","@id":"https:\/\/myeloma.ca\/fr\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/#webpage","url":"https:\/\/myeloma.ca\/fr\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/","name":"Lancement de l\u2019essai mondial Selinexor pour traiter la COVID-19 | My\u00e9lome Canada","description":"Selinexor, un m\u00e9dicament approuv\u00e9 par la Food and Drug Administration (FDA) pour le traitement des patients atteints d\u2019un my\u00e9lome multiple r\u00e9cidivant ou r\u00e9fractaire, est en cours d\u2019\u00e9valuation dans le cadre d\u2019un essai al\u00e9atoire mondial comme traitement potentiel pour les patients hospitalis\u00e9s atteints d\u2019une infection s\u00e9v\u00e8re \u00e0 la COVID-19. Cliquez ici pour en savoir plus (en","inLanguage":"fr-FR","isPartOf":{"@id":"https:\/\/myeloma.ca\/fr\/#website"},"breadcrumb":{"@id":"https:\/\/myeloma.ca\/fr\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/#breadcrumblist"},"author":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"creator":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"datePublished":"2020-07-07T00:00:00-05:00","dateModified":"2020-07-07T00:00:00-05:00"},{"@type":"WebSite","@id":"https:\/\/myeloma.ca\/fr\/#website","url":"https:\/\/myeloma.ca\/fr\/","name":"Myeloma Canada","inLanguage":"fr-FR","publisher":{"@id":"https:\/\/myeloma.ca\/fr\/#organization"}}]},"og:locale":"fr_FR","og:site_name":"My\u00e9lome Canada |","og:type":"article","og:title":"Lancement de l\u2019essai mondial Selinexor pour traiter la COVID-19 | My\u00e9lome Canada","og:description":"Selinexor, un m\u00e9dicament approuv\u00e9 par la Food and Drug Administration (FDA) pour le traitement des patients atteints d\u2019un my\u00e9lome multiple r\u00e9cidivant ou r\u00e9fractaire, est en cours d\u2019\u00e9valuation dans le cadre d\u2019un essai al\u00e9atoire mondial comme traitement potentiel pour les patients hospitalis\u00e9s atteints d\u2019une infection s\u00e9v\u00e8re \u00e0 la COVID-19. Cliquez ici pour en savoir plus (en","og:url":"https:\/\/myeloma.ca\/fr\/2020\/07\/07\/lancement-de-lessai-mondial-selinexor-pour-traiter-la-covid-19\/","article:published_time":"2020-07-07T05:00:00+00:00","article:modified_time":"2020-07-07T05:00:00+00:00","twitter:card":"summary_large_image","twitter:title":"Lancement de l\u2019essai mondial Selinexor pour traiter la COVID-19 | My\u00e9lome Canada","twitter:description":"Selinexor, un m\u00e9dicament approuv\u00e9 par la Food and Drug Administration (FDA) pour le traitement des patients atteints d\u2019un my\u00e9lome multiple r\u00e9cidivant ou r\u00e9fractaire, est en cours d\u2019\u00e9valuation dans le cadre d\u2019un essai al\u00e9atoire mondial comme traitement potentiel pour les patients hospitalis\u00e9s atteints d\u2019une infection s\u00e9v\u00e8re \u00e0 la COVID-19. Cliquez ici pour en savoir plus (en"},"aioseo_meta_data":{"post_id":"23284","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2023-10-26 13:34:40","updated":"2026-04-30 07:56:49","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/23284","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=23284"}],"version-history":[{"count":0,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/23284\/revisions"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=23284"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=23284"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=23284"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}